View in EDS HTML Full Text PDF Full Text

Current and future role of carfilzomib-based quadruplet combinations as therapy for newly diagnosed multiple myeloma.

Saved in:
Bibliographic Details
Title: Current and future role of carfilzomib-based quadruplet combinations as therapy for newly diagnosed multiple myeloma.
Authors: Landgren O; Sylvester Comprehensive Cancer Center, Myeloma Division University of Miami Miami Florida USA., Biran N; Hackensack University Medical Center Hackensack New Jersey USA., O'Donnell EK; Massachusetts General Hospital Cancer Center Boston Massachusetts USA., Mikhael J; Clinical Genomics and Therapeutics, City of Hope Cancer Center Translational Genomics Research Institute Phoenix Arizona USA., Weisel KC; Department of Oncology, Hematology and BMT University Medical Center of Hamburg-Eppendorf Hamburg Germany., Broijl A; Department of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands., Usmani SZ; Myeloma Service, Division of Hematologic Oncology, Department of Medicine Memorial Sloan Kettering Cancer Center New York New York USA., Moreau P; Hematology Department CHU Nantes Nantes France., Gay FM; Division of Hematology, AOU Città della Salute e della Scienza di Torino, and Department of Molecular Biotechnology and Health Sciences University of Torino Torino Italy., Mina R; Division of Hematology, AOU Città della Salute e della Scienza di Torino, and Department of Molecular Biotechnology and Health Sciences University of Torino Torino Italy., Rodríguez-Otero P; Cancer Center Clínica Universidad de Navarra Pamplona Navarra Spain., Jakubowiak AJ; Section of Hematology/Oncology University of Chicago Chicago Illinois USA., Derman BA; Section of Hematology/Oncology University of Chicago Chicago Illinois USA.
Source: HemaSphere [Hemasphere] 2025 Jul 16; Vol. 9 (7), pp. e70178. Date of Electronic Publication: 2025 Jul 16 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40672881
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Current and future role of carfilzomib-based quadruplet combinations as therapy for newly diagnosed multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Landgren+O%22">Landgren O</searchLink>; Sylvester Comprehensive Cancer Center, Myeloma Division University of Miami Miami Florida USA.<br /><searchLink fieldCode="AU" term="%22Biran+N%22">Biran N</searchLink>; Hackensack University Medical Center Hackensack New Jersey USA.<br /><searchLink fieldCode="AU" term="%22O'Donnell+EK%22">O'Donnell EK</searchLink>; Massachusetts General Hospital Cancer Center Boston Massachusetts USA.<br /><searchLink fieldCode="AU" term="%22Mikhael+J%22">Mikhael J</searchLink>; Clinical Genomics and Therapeutics, City of Hope Cancer Center Translational Genomics Research Institute Phoenix Arizona USA.<br /><searchLink fieldCode="AU" term="%22Weisel+KC%22">Weisel KC</searchLink>; Department of Oncology, Hematology and BMT University Medical Center of Hamburg-Eppendorf Hamburg Germany.<br /><searchLink fieldCode="AU" term="%22Broijl+A%22">Broijl A</searchLink>; Department of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands.<br /><searchLink fieldCode="AU" term="%22Usmani+SZ%22">Usmani SZ</searchLink>; Myeloma Service, Division of Hematologic Oncology, Department of Medicine Memorial Sloan Kettering Cancer Center New York New York USA.<br /><searchLink fieldCode="AU" term="%22Moreau+P%22">Moreau P</searchLink>; Hematology Department CHU Nantes Nantes France.<br /><searchLink fieldCode="AU" term="%22Gay+FM%22">Gay FM</searchLink>; Division of Hematology, AOU Città della Salute e della Scienza di Torino, and Department of Molecular Biotechnology and Health Sciences University of Torino Torino Italy.<br /><searchLink fieldCode="AU" term="%22Mina+R%22">Mina R</searchLink>; Division of Hematology, AOU Città della Salute e della Scienza di Torino, and Department of Molecular Biotechnology and Health Sciences University of Torino Torino Italy.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Otero+P%22">Rodríguez-Otero P</searchLink>; Cancer Center Clínica Universidad de Navarra Pamplona Navarra Spain.<br /><searchLink fieldCode="AU" term="%22Jakubowiak+AJ%22">Jakubowiak AJ</searchLink>; Section of Hematology/Oncology University of Chicago Chicago Illinois USA.<br /><searchLink fieldCode="AU" term="%22Derman+BA%22">Derman BA</searchLink>; Section of Hematology/Oncology University of Chicago Chicago Illinois USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101740619%22">HemaSphere</searchLink> [Hemasphere] 2025 Jul 16; Vol. 9 (7), pp. e70178. <i>Date of Electronic Publication: </i>2025 Jul 16 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101740619 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2572-9241 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225729241%22">25729241 </searchLink><i>NLM ISO Abbreviation: </i>Hemasphere <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40672881
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/hem3.70178
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70178
    Titles:
      – TitleFull: Current and future role of carfilzomib-based quadruplet combinations as therapy for newly diagnosed multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Landgren O
      – PersonEntity:
          Name:
            NameFull: Biran N
      – PersonEntity:
          Name:
            NameFull: O'Donnell EK
      – PersonEntity:
          Name:
            NameFull: Mikhael J
      – PersonEntity:
          Name:
            NameFull: Weisel KC
      – PersonEntity:
          Name:
            NameFull: Broijl A
      – PersonEntity:
          Name:
            NameFull: Usmani SZ
      – PersonEntity:
          Name:
            NameFull: Moreau P
      – PersonEntity:
          Name:
            NameFull: Gay FM
      – PersonEntity:
          Name:
            NameFull: Mina R
      – PersonEntity:
          Name:
            NameFull: Rodríguez-Otero P
      – PersonEntity:
          Name:
            NameFull: Jakubowiak AJ
      – PersonEntity:
          Name:
            NameFull: Derman BA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 07
              Text: 2025 Jul 16
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2572-9241
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: HemaSphere
              Type: main
ResultId 1